News Medical on MSN6 天
Study evaluates effectiveness and safety of TMF for chronic hepatitis B
Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for ...
腾讯网7 天
容易忽视的隐形杀手——隐匿性HBV感染丨一文读懂
导读显性乙型肝炎病毒即慢性乙型肝炎病毒（Chronic Hepatitis B,CHB）感染的特征是血清中检测到乙肝表面抗原（hepatitis B surface antigen, ...
News Medical on MSN6 小时
AGA releases updated guidelines on hepatitis B reactivation in patients on ...
The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...
Bluejay Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Brelovitug (BJT ...
Breakthrough Therapy Designation is designed to expedite the development and review of therapies that may show significant ...
Pharmabiz11 小时
US FDA grants breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for ...
US FDA grants breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for treatment of chronic hepatitis delta: Redwood City, California Thursday, January 23, 2025, ...
emjreviews.com2 天
FDA fast-tracks brelovitug for treatment of chronic hepatitis D
The drug has been granted Breakthrough Therapy designation by the FDA for the treatment of chronic hepatitis delta (CHD).